產品中心PRODUCTS CENTER

技術文章您現在的位置：首頁 > 技術文章 > BioXCell產品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

BioXCell產品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

更新時間：2023-10-31 點擊次數：772次

BioXCell熱銷產品--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

產品描述：

10F.9G2™-CP001單克隆抗體是原始10F.9G2™單克隆抗體的重組嵌合型抗體。可變結構域序列與原始10F.9G2™克隆號相同，但是恒定區(qū)序列已經從大鼠IgG2b變?yōu)樾∈驣gG1。10F.9G2™-CP001單克隆抗體在Fc片段中也含有D265A突變，使其無法與內源性Fcγ受體結合。

10F.9G2™-CP001單克隆抗體與小鼠PD-L1（程序性死亡配體1，也稱為B7-H1或CD274）反應。PD-L1是屬于Ig超家族的B7家族的I型跨膜蛋白，分子量為40kDa。PD-L1在T淋巴細胞、B淋巴細胞、NK細胞、樹突狀細胞以及IFNγ刺激的單核細胞、上皮細胞和內皮細胞上表達。PD-L1與CD4和CD8胸腺細胞以及活化的T和B淋巴細胞和骨髓細胞上的受體PD-1結合。PD-L1與PD-1的結合導致抑制TCR介導的T細胞增殖和細胞因子產生。PD-L1被認為在腫瘤免疫逃逸中起著重要作用。誘導的PD-L1表達在許多腫瘤中很常見，并導致腫瘤細胞對CD8+ T細胞介導的裂解的抗性增加。在黑色素瘤的小鼠模型中，可以通過用阻斷PD-L1和PD-1之間相互作用的抗體進行治療，暫時抑制腫瘤生長。10F.9G2™單克隆抗體已被證明可以阻斷PD-L1和PD-1之間以及PD-L1和B7-1之間的相互作用（CD80）。

產品詳情：

產品名稱	RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A) /欣博盛生物
產品貨號	CP001
產品規(guī)格	1mg
反應種屬	Mouse
克隆號	10F.9G2™-CP001
同種型	Mouse IgG1(switched from rat IgG2b)
免疫原	Mouse CD274
實驗應用	in vivo PD-L1 blockade* Immunofluorescence* Immunohistochemistry (frozen)* Flow cytometry* Western blot* *Reported for the original rat IgG2b 10F.9G2 antibody
產品形式	PBS, pH 7.0,Contains no stabilizers or preservatives
純度	>95%, Determined by SDS-PAGE
聚合	<5%, Determined by SEC
無菌處理	0.2 µm filtration
純化方式	Protein A
分子量	150 kDa
小鼠病原檢測	Ectromelia/Mousepox Virus: Negative Hantavirus: Negative K Virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Lymphocytic Choriomeningitis virus: Negative Mouse Adenovirus: Negative Mouse Cytomegalovirus: Negative Mouse Hepatitis Virus: Negative Mouse Minute Virus: Negative Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Rotavirus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Polyoma Virus: Negative Reovirus Screen: Negative Sendai Virus: Negative Theiler’s Murine Encephalomyelitis: Negative
保存條件	抗體原液保存在4°C，不能冷凍保存。
推薦抗體稀釋液	InVivoPure pH 7.0 Dilution Buffer（貨號IP0070）

該產品自上市已被多篇SCI文獻引用，品質有保證，以下是部分已發(fā)表的文獻引用：

應用

文章

體內PD-L1阻斷

(in vivo PD-L1 blockade)

1. Grasselly, C., et al. (2018). 'The Antitumor Activity of Combinations of Cytotoxic

Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent' Front

Immunol 9: 2100.

2. Stathopoulou, C., et al. (2018). 'PD-1 Inhibitory Receptor Downregulates Asparaginyl

Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory

T Cells' Immunity 49(2): 247-263 e247.

3. Jaworska, K., et al. (2015). 'Both PD-1 ligands protect the kidney from ischemia

reperfusion injury' J Immunol 194(1): 325-333.

4. Kim, J., et al. (2015). 'Memory programming in CD8(+) T-cell differentiation is

intrinsic and is not determined by CD4 help' Nat Commun 6: 7994.

5. Zander, R. A., et al. (2015). 'PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk

Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity' Cell

Host Microbe 17(5): 628-641.

體內PD-L1阻斷，流式細胞術

(in vivo PD-L1 blockade, Flow

Cytometry)

1. Aloulou, M., et al. (2016). 'Follicular regulatory T cells can be specific for the

immunizing antigen and derive from naive T cells' Nat Commun 7: 10579.

2. Ngiow, S. F., et al. (2015). 'A Threshold Level of Intratumor CD8+ T-cell PD1

Expression Dictates Therapeutic Response to Anti-PD1' Cancer Res 75(18): 3800-3811.

3. Rutigliano, J. A., et al. (2014). 'Highly pathological influenza A virus infection is

associated with augmented expression of PD-1 by functionally compromised

virus-specific CD8+ T cells' J Virol 88(3): 1636-1651.

體內PD-L1阻斷，免疫熒光

(in vivo PD-L1 blockade,

Immunofluorescence)

1.Willimsky, G., et al. (2013). 'Virus-induced hepatocellular carcinomas cause

antigen-specific local tolerance' J Clin Invest 123(3): 1032-1043.

免疫組織化學（冷凍），免疫熒光

(Immunohistochemistry (frozen),

Immunofluorescence)

1.Riella, L. V., et al. (2011). 'Essential role of PDL1 expression on nonhematopoietic

donor cells in acquired tolerance to vascularized cardiac allografts' Am J Transplant

11(4): 832-840.

<a class=

更多產品詳情請聯(lián)系 BioXCell 中國授權代理——欣博盛生物

上一篇：我的實驗樣本可以用于CUT&RUN嗎? 四大因素需考量

下一篇：RecombiMAb anti-mouse VEGFR-2抗體

返回列表>>

99久久99这里只有免费的精品_久久亚洲精品无码AV红樱桃_久久久久一级精品亚洲国产成人综合AV区_久久精品九九热无码免贵

BioXCell產品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)